Regulations.gov document
Distribution of Blood Derivatives by Registered Blood Establishments that Qualify as…
Proposed Rule · FDA-2005-N-0345 · posted Feb 2, 2006
Key facts
| Document ID | FDA-2005-N-0345-0001 |
|---|---|
| Title | Distribution of Blood Derivatives by Registered Blood Establishments that Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Policies, Requirements and Administrative Procedures; Proposed Rule |
| Document type | Proposed Rule |
| Subtype | Notice of Proposed Rulemaking (NPRM) |
| Agency | FDA |
| Docket | FDA-2005-N-0345 |
| Posted | Feb 2, 2006 |
| Federal Register citation | 71FR5200 |
| CFR | 21 CFR PARTS 203 and 205 |
| Comment period opens | Jan 31, 2006 |
| Comments due | May 3, 2006 |
| Effective date | Jan 31, 2006 |
At a glance
- 10–99 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: